Daiken Medical Co., Ltd. (TYO:7775)
Japan flag Japan · Delayed Price · Currency is JPY
412.00
+1.00 (0.24%)
Nov 16, 2026, 3:30 PM JST

Daiken Medical Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
10,33010,2909,9519,7509,1378,540
Revenue Growth
2.34%3.41%2.06%6.71%6.99%8.64%
Gross Profit
3,7623,9504,0963,9823,5303,684
Operating Income
1,0791,2771,5121,4431,0551,151
Net Income
7799221,097988712831
Earnings Per Share
27.1232.0938.1934.3924.7828.93
EPS Growth
-22.10%-15.95%11.03%38.76%-14.32%23.11%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2,0202,7782,9952,7392,5162,518
Total Debt
1,9952,2682,0512,1422,7552,933
Net Cash (Debt)
25510944597-239-415
Net Cash Growth
-96.08%-45.98%58.12%---
Net Cash Per Share
0.8717.7532.8620.78-8.32-14.45

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
4125671,1201,5559891,133
Capital Expenditures
-423-327-166-162-198-202
Free Cash Flow
-112409541,393791931
Free Cash Flow Growth
--74.84%-31.51%76.11%-15.04%210.33%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
36.42%38.39%41.16%40.84%38.63%43.14%
Operating Margin
10.45%12.41%15.19%14.80%11.55%13.48%
Pretax Margin
10.06%12.10%15.14%14.72%11.21%13.48%
Profit Margin
7.54%8.96%11.02%10.13%7.79%9.73%
FCF Margin
-0.11%2.33%9.59%14.29%8.66%10.90%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
15.1913.9612.8316.1419.4117.63
P/FCF Ratio
-53.6314.7611.4517.4715.74
PS Ratio
1.151.251.421.641.511.72